| Product Code: ETC7571953 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Parkinsons Disease Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Parkinsons Disease Market - Industry Life Cycle |
3.4 Indonesia Parkinsons Disease Market - Porter's Five Forces |
3.5 Indonesia Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Indonesia Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Indonesia Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Indonesia Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Indonesia Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Indonesia Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease among healthcare professionals and the general population |
4.2.2 Growing elderly population in Indonesia, as Parkinson's disease is more prevalent in older individuals |
4.2.3 Advancements in medical technology and research leading to improved diagnosis and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and neurologists in remote areas of Indonesia |
4.3.2 High cost of Parkinson's disease medications and treatments, limiting affordability for some patients |
4.3.3 Stigma and misconceptions surrounding neurological disorders leading to delayed diagnosis and treatment |
5 Indonesia Parkinsons Disease Market Trends |
6 Indonesia Parkinsons Disease Market, By Types |
6.1 Indonesia Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Indonesia Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Indonesia Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Indonesia Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Indonesia Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Indonesia Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Indonesia Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Indonesia Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Indonesia Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Indonesia Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Indonesia Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Indonesia Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Indonesia Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Indonesia Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Indonesia Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Indonesia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Indonesia Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Indonesia Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Indonesia Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Indonesia Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Indonesia Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Indonesia Parkinsons Disease Market Export to Major Countries |
7.2 Indonesia Parkinsons Disease Market Imports from Major Countries |
8 Indonesia Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease in Indonesia |
8.2 Number of neurologists specializing in movement disorders practicing in Indonesia |
8.3 Adoption rate of new Parkinson's disease treatment guidelines by healthcare providers in Indonesia |
9 Indonesia Parkinsons Disease Market - Opportunity Assessment |
9.1 Indonesia Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Indonesia Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Indonesia Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Indonesia Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Indonesia Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Indonesia Parkinsons Disease Market - Competitive Landscape |
10.1 Indonesia Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here